Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1382

Similar articles for PubMed (Select 16170176)

3.
4.

Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.

Kaluzny AD, Ricketts T 3rd, Warnecke R, Ford L, Morrissey J, Gillings D, Sondik EJ, Ozer H, Goldman J.

J Natl Cancer Inst. 1989 Nov 15;81(22):1717-25.

PMID:
2681795
5.

Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.

Kaluzny AD, Lacey LM, Warnecke R, Hynes DM, Morrissey J, Ford L, Sondik E.

Health Serv Res. 1993 Jun;28(2):159-82.

6.

Therapy: state-of-the-art assessment of quality. The National Cancer Institute perspective.

Ford LG.

Cancer. 1989 Jul 1;64(1 Suppl):219-222; discussion 240-3.

PMID:
2655874
7.

Use of complementary medicine by adult patients participating in cancer clinical trials.

Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J.

Oncol Nurs Forum. 2000 May;27(4):623-30.

PMID:
10833691
8.

Community-based clinical oncology research trials for cancer-related fatigue.

Jean-Pierre P, Mustian K, Kohli S, Roscoe JA, Hickok JT, Morrow GR.

J Support Oncol. 2006 Nov-Dec;4(10):511-6. Review.

PMID:
17136867
9.
10.
11.

Clinical trials in the community. The community clinical oncology program experience.

Cobau CD.

Cancer. 1994 Nov 1;74(9 Suppl):2694-700. Review.

PMID:
7954289
12.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
13.
14.

Complementary and alternative medicine research and cooperative groups: can it happen?

O'Mara A.

J Pediatr Oncol Nurs. 2006 Sep-Oct;23(5):258-60.

PMID:
16902079
15.
16.

Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.

Efficace F, Horneber M, Lejeune S, Van Dam F, Leering S, Rottmann M, Aaronson NK.

J Clin Epidemiol. 2006 Dec;59(12):1257-65. Epub 2006 Jul 3. Review.

PMID:
17098568
17.

The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.

Kantor M.

J Am Coll Radiol. 2009 Apr;6(4):254-62. doi: 10.1016/j.jacr.2008.09.012.

PMID:
19327658
18.

Cancer complementary and alternative medicine research at the US National Cancer Institute.

Jia L.

Chin J Integr Med. 2012 May;18(5):325-32. doi: 10.1007/s11655-011-0950-5. Epub 2012 Jan 12.

PMID:
22241505
19.

Performance in quasi-firms: an example from the Community Clinical Oncology Program.

Lacey LM, Hynes DM, Kaluzny AD.

J Health Hum Resour Adm. 1992 Winter;14(3):307-26.

PMID:
10118501
20.

Adapting clinical trials networks to promote cancer prevention and control research.

Weiner BJ, McKinney MM, Carpenter WR.

Cancer. 2006 Jan 1;106(1):180-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk